Trials / Completed
CompletedNCT04315038
Metabolomics Profiling Research of Human Cerebrospinal Fluid in Aging Process
Metabolomics Profiling and Biomarker Research of Human Cerebrospinal Fluid in Aging Process and Age-related Neurodegenerative Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 190 (actual)
- Sponsor
- Chang Gung Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
Perform quantitative metabolomics on human cerebrospinal fluid (CSF) samples and establish the first human CSF Metabolome Database of aging process in Taiwan.
Detailed description
Metabolomics is new science based on metabolite profiles in biofluids and tissues, which under bioinformatics approaches and analyses could help to characterize metabolomic status of CSF in aging process. In this prospective study, the investigators plan to enroll 200 health volunteers and 40 neurodegenerative diseases patients with received operation under spinal anesthesia. Blood and CSF samples will be analyzed using hydrogen-1 nuclear magnetic resonance (1H-NMR) and lipid chromatography-mass spectrometry (LC-MS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | spinal anesthesia | Plan to enroll 200 health volunteers and 40 neurodegenerative diseases patients with received spinal anesthesia. Blood will be collected at time point of pre-anesthesia 10 minutes and CSF samples will be collected at time point during spinal anesthesia induction. Blood will be collected, drawn into EDTA-coated tube. |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2021-07-31
- Completion
- 2021-07-31
- First posted
- 2020-03-19
- Last updated
- 2022-01-31
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04315038. Inclusion in this directory is not an endorsement.